Bioten Co., Ltd Logo

Bioten Co., Ltd

Develops biotech health supplements, animal feed additives, and functional cosmetics.

289170 | KO

Overview

Corporate Details

ISIN(s):
KR7289170003
LEI:
Country:
South Korea
Address:
전북특별자치도 정읍시 첨단2로 64 -, 정읍시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Bioten Co., Ltd. is a biotechnology company engaged in the development, manufacturing, and sale of health supplements, animal feed additives, and functional cosmetics. Established in 2011, the company focuses on commercializing scientific research and technology. Its product line includes health-functional foods such as probiotics, collagen, and a proprietary solubilized curcumin designed for enhanced absorption and immune support. The company also develops animal feed additives and explores therapeutic treatments through its drug pipeline research.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-13 00:00
Regulatory Filings
본점소재지변경
Korean 5.1 KB
2025-07-17 00:00
Regulatory Filings
[기재정정]신규시설투자등
Korean 13.2 KB
2025-06-26 00:00
Regulatory Filings
기업설명회(IR)개최결과
Korean 6.9 KB
2025-04-16 00:00
Regulatory Filings
신규시설투자등
Korean 7.9 KB
2025-03-26 00:00
AGM Information
정기주주총회결과
Korean 25.4 KB
2025-03-26 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 9.7 KB
2025-03-18 00:00
Audit Report / Information
감사보고서제출
Korean 9.6 KB
2025-03-18 00:00
Annual Report
사업보고서 (2024.12)
Korean 808.5 KB
2025-03-14 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 9.7 KB
2025-03-11 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 14.7 KB
2025-03-11 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 155.9 KB
2025-02-18 00:00
M&A Activity
주요사항보고서(유형자산양도결정)
Korean 15.2 KB
2024-12-13 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.2 KB
2024-11-19 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 74.5 KB
2024-11-19 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 22.4 KB

Automate Your Workflow. Get a real-time feed of all Bioten Co., Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Bioten Co., Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Bioten Co., Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Modalis Therapeutics Corporation Logo
Develops epigenome editing therapies for genetic muscular, heart, and CNS disorders.
Japan
4883
Moderna, Inc. Logo
Pioneering mRNA science to create transformative medicines and vaccines for diverse diseases.
United States of America
MRNA
Molecular Partners AG Logo
Pioneering DARPin protein drugs for complex diseases in oncology and virology.
Switzerland
MOLN
Moleculin Biotech, Inc. Logo
Developing therapies for hard-to-treat tumors (like AML) and viruses.
United States of America
MBRX
Monte Rosa Therapeutics, Inc. Logo
Develops molecular glue degraders to target undruggable proteins in cancer and immune diseases.
United States of America
GLUE
Develops LNP drug delivery systems for severe diseases, offering R&D to GMP manufacturing support.
South Korea
322970
MoonLake Immunotherapeutics Logo
Developing Nanobody therapies for inflammatory and immunologic diseases like psoriatic arthritis.
United States of America
MLTX
MORISHITA JINTAN CO.,LTD. Logo
Manufactures health products and provides OEM/ODM services using advanced encapsulation technology.
Japan
4524
MorphoSys AG Logo
Biopharma company creating antibody therapies for oncology, with a focus on blood cancers.
Germany
MOR
MUSTANG BIO, INC. Logo
Developing CAR T-cell and gene therapies for cancers and rare genetic disorders.
United States of America
MBIO

Talk to a Data Expert

Have a question? We'll get back to you promptly.